Clinical trial benchmarking

So, how can organizations improve clinical trials to maximize efficiency and ensure effectiveness? Further, how can organizations leverage clinical trial results to prepare the market for product launch? The choice of clinical trial investigator can considerably alter the course of a clinical trial. However, finding and retaining top clinical trial investigators is a separate challenge.

In addition to these, benchmarks are carried out on patient engagement, portfolio management, resource management and so on. Patient benchmarks focus on the speed of patient recruitment, retention and the cost of engagement campaigns to increase patient awareness, as well as measuring the success of the patient engagement programs. Portfolio management benchmarking using predictive analysis enables identifying market opportunity net present value , competition and timelines for drug development.

Increased utilization of full-time equivalent FTE resources, mainly for the CRAs and project managers at the site level, with competitive FTE rates, serves as an opportunity to reduce overall staff costs. This has resulted in companies benchmarking resource management to measure the efficient use of spend on contracted and insourced FTE resources.

All these practices are directed toward identifying opportunities and insights in the form of cost savings, process efficiencies, technology impact, talent retention, innovation, best practices and strategy. Register Now. Beroe is the World's leading provider of Procurement Intelligence and Supplier compliance solutions. We work with over 10, companies worldwide, including of the Fortune Supplier Financial Risk Rating. Listen to this article. Introduction Pharma companies use performance and competitive benchmarking to identify opportunities during their drug development cycle.

Protocol Amendment Benchmarking A number of initiatives have been introduced by pharma companies to optimize protocol design.

Fair Market Value Benchmarking With increasing scrutiny and regulations from government agencies such as The Physician Payments Sunshine Act , the pharma industry is forced to benchmark fair market value FMV more precisely than before. Under this, the key parameters benchmarked are: CRO Site Performance : Benchmarking is based on the history of successful completion of trials, how much the CRO maintains confidentiality, therapeutic expertise, geographic capability, brand value and size of the operation.

Conclusion The discussion above covers only a few of the various benchmarking activities practiced by pharma. Related Insights. Comment: Leave this field empty:. City x. Distance 50 miles miles miles miles. Advanced Search. Researchers Search the database to stay up to date on developments in your field, find collaborators, and identify unmet needs.

Study Record Managers Learn about registering studies and about submitting their results after study completion. National Library of Medicine U. National Institutes of Health U.